Melasma-like hyperpigmentation: A rare side effect of imatinib mesylate
Imatinib mesylate is an oral tyrosine kinase inhibitor used chiefly to treat chronic myeloid leukemia. In the literature, hypopigmentation is a commonly reported side effect of imatinib therapy; however, the cases of melasma-like hyperpigmentation due to imatinib have also been sparingly reported. W...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Σειρά: | Journal of the Scientific Society |
| Θέματα: | |
| Διαθέσιμο Online: | http://www.jscisociety.com/article.asp?issn=0974-5009;year=2023;volume=50;issue=2;spage=275;epage=277;aulast=Agrawal |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|